Author information:
(1)Sunnybrook Health Sciences Centre, University of Toronto, 2075 Bayview Ave, 
T2-041, Toronto, ON, M4N 3M5, Canada. Electronic address: 
teresa.petrella@sunnybrook.ca.
(2)Gustave Roussy and Université Paris-Sud, 114 Rue Edouard Vaillant, 94800 
Villejuif, France. Electronic address: caroline.robert@gustaveroussy.fr.
(3)Medical University of Graz, Auenbruggerpl. 2, 8036 Graz, Graz, Austria. 
Electronic address: erika.richtig@medunigraz.at.
(4)Segal Cancer Centre, Jewish General Hospital, Rossy Cancer Network, and 
McGill University, 3755 Ch de la Côte-Sainte-Catherine, Montreal, QC, H3T 1E2, 
Canada. Electronic address: wilsonmiller@gmail.com.
(5)Karolinska Institute, Solnavägen 1, 171 77 Solna, Stockholm, Sweden. 
Electronic address: giuseppe.masucci@ki.se.
(6)Princess Alexandra Hospital and The University of Queensland, 199 Ipswich Rd, 
Woolloongabba, Brisbane, QLD 4102, Australia. Electronic address: 
euan.walpole@health.qld.gov.au.
(7)APHP, Dermatology and CIC, Université Paris Diderot, Hôpital Saint-Louis, 1 
Avenue Claude Vellefaux, 75010 Paris, France. Electronic address: 
celeste.lebbe@aphp.fr.
(8)Queen Elizabeth Hospital Birmingham, Mindelsohn Way, Birmingham B15 2TH, UK. 
Electronic address: N.M.Steven@bham.ac.uk.
(9)The Churchill Hospital and The University of Oxford, Old Rd, Headington, 
Oxford OX3 7LE, UK. Electronic address: mark.middleton@oncology.ox.ac.uk.
(10)Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. 
Electronic address: darcy_hille@merck.com.
(11)Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. 
Electronic address: wei.zhou2@merck.com.
(12)Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, NJ 07033, USA. 
Electronic address: nageatte.ibrahim@merck.com.
(13)Olivia Newton-John Cancer Research Institute, Austin Health, School of 
Cancer Medicine, La Trobe University, 145 Studley Road, Heidelberg VIC 3084, 
Melbourne, Australia. Electronic address: jonathan.cebon@onjcri.org.au.